At CTA event, federal officials outline AI ambitions as clinicians debate risks

Federal healthcare agencies, led by CMS and coordinated with the FDA, are advancing frameworks to regulate and reimburse AI in clinical care, including expanding the ACCESS model to integrate AI-enabled chronic condition management with a focus on outcomes and cost reduction.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.